Cargando…
Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry
HIV elite controllers maintain a population of CD4 + T cells endowed with high avidity for Gag antigens and potent effector functions. How these HIV-specific cells avoid infection and depletion upon encounter with the virus remains incompletely understood. Ex vivo characterization of single Gag-spec...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792008/ https://www.ncbi.nlm.nih.gov/pubmed/35082297 http://dx.doi.org/10.1038/s41467-022-28130-0 |
_version_ | 1784640313221971968 |
---|---|
author | Claireaux, Mathieu Robinot, Rémy Kervevan, Jérôme Patgaonkar, Mandar Staropoli, Isabelle Brelot, Anne Nouël, Alexandre Gellenoncourt, Stacy Tang, Xian Héry, Mélanie Volant, Stevenn Perthame, Emeline Avettand-Fenoël, Véronique Buchrieser, Julian Cokelaer, Thomas Bouchier, Christiane Ma, Laurence Boufassa, Faroudy Hendou, Samia Libri, Valentina Hasan, Milena Zucman, David de Truchis, Pierre Schwartz, Olivier Lambotte, Olivier Chakrabarti, Lisa A. |
author_facet | Claireaux, Mathieu Robinot, Rémy Kervevan, Jérôme Patgaonkar, Mandar Staropoli, Isabelle Brelot, Anne Nouël, Alexandre Gellenoncourt, Stacy Tang, Xian Héry, Mélanie Volant, Stevenn Perthame, Emeline Avettand-Fenoël, Véronique Buchrieser, Julian Cokelaer, Thomas Bouchier, Christiane Ma, Laurence Boufassa, Faroudy Hendou, Samia Libri, Valentina Hasan, Milena Zucman, David de Truchis, Pierre Schwartz, Olivier Lambotte, Olivier Chakrabarti, Lisa A. |
author_sort | Claireaux, Mathieu |
collection | PubMed |
description | HIV elite controllers maintain a population of CD4 + T cells endowed with high avidity for Gag antigens and potent effector functions. How these HIV-specific cells avoid infection and depletion upon encounter with the virus remains incompletely understood. Ex vivo characterization of single Gag-specific CD4 + T cells reveals an advanced Th1 differentiation pattern in controllers, except for the CCR5 marker, which is downregulated compared to specific cells of treated patients. Accordingly, controller specific CD4 + T cells show decreased susceptibility to CCR5-dependent HIV entry. Two controllers carried biallelic mutations impairing CCR5 surface expression, indicating that in rare cases CCR5 downregulation can have a direct genetic cause. Increased expression of β-chemokine ligands upon high-avidity antigen/TCR interactions contributes to autocrine CCR5 downregulation in controllers without CCR5 mutations. These findings suggest that genetic and functional regulation of the primary HIV coreceptor CCR5 play a key role in promoting natural HIV control. |
format | Online Article Text |
id | pubmed-8792008 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-87920082022-02-07 Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry Claireaux, Mathieu Robinot, Rémy Kervevan, Jérôme Patgaonkar, Mandar Staropoli, Isabelle Brelot, Anne Nouël, Alexandre Gellenoncourt, Stacy Tang, Xian Héry, Mélanie Volant, Stevenn Perthame, Emeline Avettand-Fenoël, Véronique Buchrieser, Julian Cokelaer, Thomas Bouchier, Christiane Ma, Laurence Boufassa, Faroudy Hendou, Samia Libri, Valentina Hasan, Milena Zucman, David de Truchis, Pierre Schwartz, Olivier Lambotte, Olivier Chakrabarti, Lisa A. Nat Commun Article HIV elite controllers maintain a population of CD4 + T cells endowed with high avidity for Gag antigens and potent effector functions. How these HIV-specific cells avoid infection and depletion upon encounter with the virus remains incompletely understood. Ex vivo characterization of single Gag-specific CD4 + T cells reveals an advanced Th1 differentiation pattern in controllers, except for the CCR5 marker, which is downregulated compared to specific cells of treated patients. Accordingly, controller specific CD4 + T cells show decreased susceptibility to CCR5-dependent HIV entry. Two controllers carried biallelic mutations impairing CCR5 surface expression, indicating that in rare cases CCR5 downregulation can have a direct genetic cause. Increased expression of β-chemokine ligands upon high-avidity antigen/TCR interactions contributes to autocrine CCR5 downregulation in controllers without CCR5 mutations. These findings suggest that genetic and functional regulation of the primary HIV coreceptor CCR5 play a key role in promoting natural HIV control. Nature Publishing Group UK 2022-01-26 /pmc/articles/PMC8792008/ /pubmed/35082297 http://dx.doi.org/10.1038/s41467-022-28130-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Claireaux, Mathieu Robinot, Rémy Kervevan, Jérôme Patgaonkar, Mandar Staropoli, Isabelle Brelot, Anne Nouël, Alexandre Gellenoncourt, Stacy Tang, Xian Héry, Mélanie Volant, Stevenn Perthame, Emeline Avettand-Fenoël, Véronique Buchrieser, Julian Cokelaer, Thomas Bouchier, Christiane Ma, Laurence Boufassa, Faroudy Hendou, Samia Libri, Valentina Hasan, Milena Zucman, David de Truchis, Pierre Schwartz, Olivier Lambotte, Olivier Chakrabarti, Lisa A. Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry |
title | Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry |
title_full | Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry |
title_fullStr | Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry |
title_full_unstemmed | Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry |
title_short | Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry |
title_sort | low ccr5 expression protects hiv-specific cd4+ t cells of elite controllers from viral entry |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792008/ https://www.ncbi.nlm.nih.gov/pubmed/35082297 http://dx.doi.org/10.1038/s41467-022-28130-0 |
work_keys_str_mv | AT claireauxmathieu lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry AT robinotremy lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry AT kervevanjerome lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry AT patgaonkarmandar lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry AT staropoliisabelle lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry AT brelotanne lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry AT nouelalexandre lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry AT gellenoncourtstacy lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry AT tangxian lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry AT herymelanie lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry AT volantstevenn lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry AT perthameemeline lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry AT avettandfenoelveronique lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry AT buchrieserjulian lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry AT cokelaerthomas lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry AT bouchierchristiane lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry AT malaurence lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry AT boufassafaroudy lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry AT hendousamia lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry AT librivalentina lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry AT hasanmilena lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry AT zucmandavid lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry AT detruchispierre lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry AT schwartzolivier lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry AT lambotteolivier lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry AT chakrabartilisaa lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry |